BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 2:41:00 PM | Browse: 1063 | Download: 1162
 |
Received |
|
2013-10-26 12:24 |
 |
Peer-Review Started |
|
2013-10-27 12:24 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-01-11 19:17 |
 |
Revised |
|
2014-01-22 17:00 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-02-27 11:21 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-02-27 11:28 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-03-26 11:19 |
 |
Publish the Manuscript Online |
|
2014-04-14 10:49 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Inhibition of host immune response in colorectal cancer: Human leukocyte antigen-G and beyond
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marica Garziera and Giuseppe Toffoli |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Associazione Italiana per la Ricerca sul Cancro (AIRC), Special Program Molecular Clinical Oncology, 5X1000 |
12214 (G.T.) |
| European Research Council, Programme ‘‘Ideas’’, Proposal |
269051 (G.T., F.R.) |
|
| Corresponding Author |
Marica Garziera, PhD, Experimental and Clinical Pharmacology Unit, CRO Aviano National Cancer Institute, via Franco Gallini 2, 33081 Aviano, Italy. mgarziera@cro.it |
| Key Words |
Colorectal cancer; Human leukocyte antigen-G; Immune score; T lymphocytes; Untranslated regions |
| Core Tip |
Colorectal cancer (CRC) prognosis is strictly associated with the immune contexture of tumor microenvironment. IS improves prognostic prediction in CRC. Human leukocyte antigen-G (HLA-G) through its direct inhibitory functions on NK cells and cytotoxic T and B lymphocytes represents a crucial tumor-driven immune escape molecule. This review highlights the current knowledge on HLA-G in CRC and in related inflammatory diseases. HLA-G genetic setting and circulating/soluble profiles need to be defined to comprehend CRC strategies to avoid host immune defences. We suggest that HLA G could represent a novel prognostic immune biomarker to associate with the Immune Score to better characterize host immune response in CRC. |
| Publish Date |
2014-04-14 10:49 |
| Citation |
Garziera M, Toffoli G. Inhibition of host immune response in colorectal cancer: Human leukocyte antigen-G and beyond. World J Gastroenterol 2014; 20(14): 3778-3794 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i14/3778.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i14.3778 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.